Lynda K Hawkins

Title: Lynda K Hawkins: Innovator in Adenoviral Vector Technology

Introduction

Lynda K Hawkins is a prominent inventor based in Germantown, MD (US). She has made significant contributions to the field of biotechnology, particularly in the development of adenoviral vectors for treating diseases.

Latest Patents

Hawkins holds a patent for "Adenoviral vectors for treating disease." This patent involves adenoviral vectors, including mutant adenoviruses, that have restriction sites in the E3 region. These vectors facilitate the partial or total deletion of specific genes and allow for the substitution of heterologous genes in the E3 region. The heterologous genes are operably linked to endogenous adenoviral transcriptional control sequences, exhibiting an expression pattern similar to the endogenous adenoviral genes they replace. This technology has applications for diagnosing or treating diseases, particularly those involving unwanted cell growth, such as cancer. She has 1 patent to her name.

Career Highlights

Hawkins has worked with Onyx Pharmaceuticals, Inc., where she has been instrumental in advancing research in adenoviral vector technology. Her work has contributed to the understanding and potential treatment of various diseases.

Collaborations

Throughout her career, Hawkins has collaborated with notable colleagues, including Terry Hermiston and Leisa Johnson. These collaborations have further enhanced her research and development efforts in the field.

Conclusion

Lynda K Hawkins is a key figure in the innovation of adenoviral vectors, with her work paving the way for new therapeutic approaches to combat diseases like cancer. Her contributions continue to impact the biotechnology landscape significantly.